Henry Schein traded at $73.68 this Thursday March 26th, decreasing $0.57 or 0.77 percent since the previous trading session. Looking back, over the last four weeks, Henry Schein lost 10.57 percent. Over the last 12 months, its price rose by 6.17 percent. Looking ahead, we forecast Henry Schein to be priced at 72.00 by the end of this quarter and at 65.72 in one year, according to Trading Economics global macro models projections and analysts expectations.
Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment distributes consumable products, laboratory products, equipment repair services, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions, medical practitioners and ambulatory surgery centers. The Technology and value-added services segments provides software, technology and other value-added services to health care practitioners. It also offers practice management software systems for dental and medical practitioners. The Company's value-added practice solutions include financial services on a non-recourse basis, e-services, practice technology, network and hardware services.